Cargando…

Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis

Aim: We aimed to quantify the effects of immune checkpoint inhibitors (ICIs) on the prognosis of COVID-19. Materials & methods: A meta-analysis was conducted and the hospitalization, severe disease and mortality rates were assessed. Thirteen studies comprising of 4614 cancer patients with COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Wenwei, Ye, Ying, Zuo, Lugen, Song, Ting, Xu, Qing, Wang, Yinghong, Qian, Jun, Tian, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388614/ https://www.ncbi.nlm.nih.gov/pubmed/34431319 http://dx.doi.org/10.2217/imt-2021-0007

Ejemplares similares

Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
por: Nso, Nso, et al.
Publicado: (2020)

Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
por: Zou, Yutian, et al.
Publicado: (2020)

Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Chen, Baoqing, et al.
Publicado: (2022)

Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis
por: Pei, Wen-Guang, et al.
Publicado: (2023)

Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2021)

Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review
por: Kim, Bum Jun, et al.
Publicado: (2017)

Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis
por: Jiang, Wen, et al.
Publicado: (2017)

Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors
por: Li, Nijiao, et al.
Publicado: (2023)

How to Choose a Survival Period? The Impact of Antibiotic Use on OS or PFS in NSCLC Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Chen, Hua, et al.
Publicado: (2021)

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis
por: Cavanna, Luigi, et al.
Publicado: (2019)

Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?
por: Roviello, Giandomenico, et al.
Publicado: (2019)

Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma
por: Petersohn, Svenja, et al.
Publicado: (2023)

Efficacy and safety of cyclosporine-based regimens for primary immune thrombocytopenia: a systematic review and meta-analysis
por: Li, Xiaojing, et al.
Publicado: (2023)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis
por: Jin, Zhe, et al.
Publicado: (2020)

Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis
por: Li, Yan, et al.
Publicado: (2023)

Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2020)

The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review
por: Swildens, Kyra X, et al.
Publicado: (2022)

Effects of Prior Antiplatelet Therapy on the Prognosis of Primary Intracerebral Hemorrhage: A Meta-analysis
por: Yu, Hai-Han, et al.
Publicado: (2017)

The expression of circRNAs as a promising biomarker in the diagnosis and prognosis of human cancers: a systematic review and meta-analysis
por: Ding, Han-Xi, et al.
Publicado: (2017)

Meta-analysis indicating that high ALCAM expression predicts poor prognosis in colorectal cancer
por: Zhang, Yeqing, et al.
Publicado: (2017)

Efficacy of PD-1/PD-L1 inhibitors against pretreated advanced cancer: a systematic review and meta-analysis
por: Hu, Hao, et al.
Publicado: (2018)

Which treatment is preferred for advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor in second-line therapy? A meta-analysis comparing immune checkpoint inhibitor, tyrosine kinase inhibitor and chemotherapy
por: Wu, Di, et al.
Publicado: (2017)

The effect of pathological fractures on the prognosis of patients with osteosarcoma: a meta-analysis of 14 studies
por: Zhou, Yifei, et al.
Publicado: (2017)

High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis
por: Nie, Dan, et al.
Publicado: (2017)

LncRNA NORAD as a Novel Predictor of Lymph Node Metastasis and Prognosis in Solid Tumors: A Systematic Review and Meta-Analysis
por: Ye, Tao, et al.
Publicado: (2020)

Do histological variants in urothelial carcinoma of the bladder portend poor prognosis? A systematic review and meta-analysis
por: Chen, Qingke, et al.
Publicado: (2017)

The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis
por: Xu, Huilin, et al.
Publicado: (2020)

Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis
por: Akturk, H. K., et al.
Publicado: (2019)

Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
por: Guo, Yun-Ran, et al.
Publicado: (2023)

Renal impairment and the prognosis of endovascular thrombectomy: a meta-analysis and systematic review
por: Wang, Rui, et al.
Publicado: (2022)

Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis
por: Peng, Ling, et al.
Publicado: (2017)

The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis
por: Zhang, Jie, et al.
Publicado: (2017)

Circulating copeptin level and the clinical prognosis of patients with chronic liver disease
por: Tan, Hao-Qian, et al.
Publicado: (2023)

Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017)

The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses
por: Byrne, Tara, et al.
Publicado: (2017)

Efficacy and safety of rituximab for minors with immune thrombocytopenia: a systematic review and meta-analysis
por: Qu, Min, et al.
Publicado: (2020)

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers
por: Tian, Yijun, et al.
Publicado: (2017)

Assessment of the safety and efficacy of combination chemotherapy and PD-1/PD-L1 inhibitor treatment of breast cancer: A meta-analysis
por: Qian, Da, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bu5i7011f3uqq9fnfd88t4n7hh